T lymphocytes of ESRD patients had lower ability to proliferate and produce IL-2 after stimulation. Adding IL-2 to T-lymphocytes of dialysis patients did no reverse the proliferation defect.
(1–84) PTH increased lymphocytes proliferation in dose-dependent manner, increased IL-2 production. (1–34) PTH increased lymphocytes proliferation but lesser than (1–84) PTH. (1–84) PTH had no effect on CD4/CD8 ratio. Both PTH stimulated cAMP production.
T-lymphocytes from rats: 18 nephrectomy v/s 17 healthy. Then 6/18 and 9/17 had parathyroidectomy. 72 hours incubation.
Rat (1–84) PTH
Stimulation with: Phytohemagglutinin.
T-lymphocyte response to stimulation was higher in uremic rats. Parathyroidectomy reduced T-cell response to PTH which stimulation enhanced T-cell stimulation (dose dependent) only in uremic rats.
54 patient with ESRD: 26 normal serum PTH. 28 high serum PTH. Controls are heathy subjects.
PTH measured with radioimmunoassay.
N/A
Both groups had decreased T-lymphocytes number. Decreased in total CD4 cells number and CD4/CD8 ratio in the group of high serum PTH. Higher total CD8 number in patient with normal serum PTH. PTH shows a linear correlation with CD8 cells and reverse correlation with total T lymphocytes, CD4, and CD4/CD8 ratio.
Population of hemodialysis patients: 26 normal PTH, 28 elevated PTH
PTH measured by immunoradiometry
N/A
Both groups have decreased total number of lymphocytes. Reverse correlation between levels of PTH and number of T-lymphocytes. linear correlation between levels of PTH and IL-2 Linear correlation between CD8 cells and PTH.
Stimulation with: anti-CD3 antibody, PPD and allo- antigens.
No correlation between PTH levels and the stimulation index. PTH decreased the stimulation index in hemodialysis patients and increased it in normal subjects at 10 ng/dl.
Both group had lower than normal total lymphocytes number. CD4 and CD4/CD8 were higher in high PTH group. Higher secretion of IgM in both group compared to controlled with normal kidney function. Positive correlation between PTH levels and proliferation of lymphoproliferative response of CD4. No difference if the patients were treated by nifedipine and 1,25-hydroxyvitamin D.